Rapamycin and rapalogs for tuberous sclerosis complex.

Autor: Sasongko TH; Department of Physiology, School of Medicine, International Medical University, Kuala Lumpur, Malaysia.; Institute for Research, Development, and Innovation, International Medical University, Kuala Lumpur, Malaysia., Kademane K; Department of Pharmacology, Arunai Medical College and Hospital, Tiruvannamalai, Tamilnadu, India., Chai Soon Hou S; Perdana University - Royal College of Surgeons in Ireland (RCSI) School of Medicine, Kuala Lumpur, Malaysia., Jocelyn TXY; Perdana University - Royal College of Surgeons in Ireland (RCSI) School of Medicine, Kuala Lumpur, Malaysia., Zabidi-Hussin Z; Faculty of Medicine, University of Cyberjaya, Selangor, Malaysia.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2023 Jul 11; Vol. 7. Cochrane AN: CD011272. Date of Electronic Publication: 2023 Jul 11.

Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis.

Autor: Kaufmann WE; Boston Children's Hospital, Boston, MA, 02115, USA. walter.kaufmann@childrens.harvard.edu.; Emory University School of Medicine, Atlanta, GA, 30322, USA. walter.kaufmann@childrens.harvard.edu., Luu S; Rutgers New Jersey Medical School, Newark, NJ, USA., Budimirovic DB; Kennedy Krieger Institute and Department of Psychiatry & Behavioral Sciences-Child Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2024 Dec 06; Vol. 25 (1), pp. 7. Date of Electronic Publication: 2024 Dec 06.

New staging criteria predicting m-tor inhibitors treatment effect of renal angiomyolipoma in tuberous sclerosis complex patients.

Autor: Wang W; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Qiu D; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China.; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, V6H 3Z6, Canada., Zhao Y; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Wang Z; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Wang X; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Li Y; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Liu Y; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China., Liao Z; Department of Urolog, Xiangya Hospital, Central South University, 410008, Changsha, China. zc.liao2020@gmail.com.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, 410008, Changsha, China. zc.liao2020@gmail.com., Zhang Y; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China. beijingzhangyushi@126.com.

Publikováno v: World journal of urology [World J Urol] 2024 Sep 20; Vol. 42 (1), pp. 532. Date of Electronic Publication: 2024 Sep 20.